Chemical Compound

(11S,15S,17S)-7-hydroxy-5-[(11S,15S,17S)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione

CAS Registry Number 95828-47-0
(11S,15S,17S)-7-hydroxy-5-[(11S,15S,17S)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione 结构式
Primary record

(11S,15S,17S)-7-hydroxy-5-[(11S,15S,17S)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione

库存
4,107 克
纯度
98.3 %
CAS
95828-47-0

化合物标识与属性

CAS
95828-47-0
PubChem CID
25023403
SMILES
C[C@H]1C2=C([C@H]3[C@@H](O1)CC(=O)O3)C(=O)C4=C(C2=O)C=C(C=C4O)C5=CC6=C(C(=C5)O)C(=O)C7=C(C6=O)[C@@H](O[C@@H]8[C@H]7OC(=O)C8)C
Canonical SMILES
C[C@@H]1O[C@H]2CC(=O)O[C@H]2C2=C1C(=O)c1cc(-c3cc(O)c4c(c3)C(=O)C3=C(C4=O)[C@@H]4OC(=O)C[C@@H]4O[C@H]3C)cc(O)c1C2=O

名称与同义词

  • Crisamicin A
  • CRS-A
  • RefChem:128471
  • UNII-KJ7654W82V
  • KJ7654W82V
  • SCHEMBL29884289
  • BBF-01076
  • C32H22O12
  • C32-H22-O12
  • J40.706B
  • 95828-47-0
  • Q27282289
  • (11S,15S,17S)-7-hydroxy-5-[(11S,15S,17S)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione
  • (11S,15S,17S)-7-hydroxy-5-((11S,15S,17S)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo(8.7.0.03,8.011,15)heptadeca-1(10),3(8),4,6-tetraen-5-yl)-17-methyl-12,16-dioxatetracyclo(8.7.0.03,8.011,15)heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione
  • (11S,15S,17S)-7-hydroxy-5-[(11S,15S,17S)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione
  • (3aS)-5beta,5 beta-Dimethyl-10,10 -dihydroxy-3,3 ,3abeta,3 abeta,5,5 ,6,6 ,11,11 ,11bbeta,11 bbeta-dodecahydro-8,8 -bi[2H-furo[3,2-b]naphtho[2,3-d]pyran]-2,2 ,6,6 ,11,11 -hexaone
  • (3aS)-5beta,5'beta-Dimethyl-10,10'-dihydroxy-3,3',3abeta,3'abeta,5,5',6,6',11,11',11bbeta,11'bbeta-dodecahydro-8,8'-bi[2H-furo[3,2-b]naphtho[2,3-d]pyran]-2,2',6,6',11,11'-hexaone
  • (3aS,3 aS,5S,5 S,11bS,11 bS)-3,3 ,3a,3 a,5,5 ,11b,11 b-Octahydro-10,10 -dihydroxy-5,5 -dimethyl-8,8 -bi[2H-furo[3,2-b]naphtho[2,3-d]pyran]-2,2 ,6,6 ,11,11 -hexone
  • (8,8'-BI-2H-FURO(3,2-B)NAPHTHO(2,3-D)PYRAN)-2,2',6,6',11,11'-HEXONE, 3,3',3A,3'A,5,5',11B,11'B-OCTAHYDRO-10,10'-DIHYDROXY-5,5'-DIMETHYL-, (3AS,3'AS,5S,5'S,11BS,11'BS)-
  • (8,8'-BI-2H-FURO(3,2-B)NAPHTHO(2,3-D)PYRAN)-2,2',6,6',11,11'-HEXONE, 3,3',3A,3'A,5,5',11B,11'B-OCTAHYDRO-10,10'-DIHYDROXY-5,5'-DIMETHYL-, (3AS-(3A.ALPHA.,5.ALPHA.,8(3AR*,5R*,11BR*),11B.ALPHA.))-
  • (8,8'-Bi-2H-furo(3,2-b)naphtho(2,3-d)pyran)-2,2',6,6'11,11'-hexone, 3,3',3a,3'a,5,5',11b,11'b-octahydro-10,10'-dihydroxy-5,5'-dimethyl-, (3aS-(3aalpha,5alpha,8(3aR*,5R*,11bR*),11balpha))-
  • 7',10-Dihydroxy-5,5'-dimethyl-3,3',3a,3'a,5,5',11b,11'b-octahydro-2H,2'H-[8,9'-bifuro[3,2-b]naphtho[2,3-d]pyran]-2,2',6,6',11,11'-hexone
  • 7-hydroxy-5-(7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo(8.7.0.03,8.011,15)heptadeca-1(10),3(8),4,6-tetraen-5-yl)-17-methyl-12,16-dioxatetracyclo(8.7.0.03,8.011,15)heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione